258 related articles for article (PubMed ID: 23817698)
1. MicroRNAs targeting EGFR signalling pathway in colorectal cancer.
Mlcochova J; Faltejskova P; Nemecek R; Svoboda M; Slaby O
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1615-24. PubMed ID: 23817698
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.
Qu X; Yang L; Shi Q; Wang X; Wang D; Wu G
Pathol Res Pract; 2018 Dec; 214(12):1974-1979. PubMed ID: 30262429
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs involved in the EGFR pathway in glioblastoma.
Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
[TBL] [Abstract][Full Text] [Related]
7. The role of miRNA -31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type K-RAS metastatic colorectal cancer. Is it really the next best thing in miRNAs?
Sur D; Cainap C; Burz C; Havasi A; Chis IC; Vlad C; Milosevic V; Balacescu O; Irimie A
J BUON; 2019; 24(5):1739-1746. PubMed ID: 31786833
[TBL] [Abstract][Full Text] [Related]
8. miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling.
El-Daly SM; Abba ML; Patil N; Allgayer H
Sci Rep; 2016 Apr; 6():24720. PubMed ID: 27095166
[TBL] [Abstract][Full Text] [Related]
9. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer.
Mohan S; Hakami MA; Dailah HG; Khalid A; Najmi A; Zoghebi K; Halawi MA
Pathol Res Pract; 2024 Jan; 253():155016. PubMed ID: 38070221
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR.
Xing Y; Jing H; Zhang Y; Suo J; Qian M
Int J Biochem Cell Biol; 2020 Jan; 118():105643. PubMed ID: 31704502
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
Hiraide S; Takahashi M; Yoshida Y; Yamada H; Komine K; Ishioka C
Cancer Sci; 2021 Sep; 112(9):3856-3870. PubMed ID: 34288281
[TBL] [Abstract][Full Text] [Related]
13. A Novel Role for MiR-520a-3p in Regulating EGFR Expression in Colorectal Cancer.
Zhang R; Liu R; Liu C; Niu Y; Zhang J; Guo B; Zhang CY; Li J; Yang J; Chen X
Cell Physiol Biochem; 2017; 42(4):1559-1574. PubMed ID: 28738328
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer.
De Robertis M; Loiacono L; Fusilli C; Poeta ML; Mazza T; Sanchez M; Marchionni L; Signori E; Lamorte G; Vescovi AL; Garcia-Foncillas J; Fazio VM
Clin Cancer Res; 2017 Jan; 23(1):159-170. PubMed ID: 27401248
[TBL] [Abstract][Full Text] [Related]
15. [The Role of MicroRNAs in Colorectal Cancer].
Kim SW
Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
[TBL] [Abstract][Full Text] [Related]
16. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
17. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
18. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
20. Implications for KRAS status and EGFR-targeted therapies in metastatic CRC.
Normanno N; Tejpar S; Morgillo F; De Luca A; Van Cutsem E; Ciardiello F
Nat Rev Clin Oncol; 2009 Sep; 6(9):519-27. PubMed ID: 19636327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]